Related Experiment Video
Updated: Jul 6, 2026
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
[Interest of radiotherapy of rectal cancer with synchronous metastases]
H Tournat1, V Vendrely, B Cherciu
1Service de radiothérapie et d'oncologie médicale, hôpital Saint-André, 1, rue Jean-Burguet, 33075 Bordeaux, France. helene_tournat@yahoo.fr
Purpose:
There is no consensus about the treatment of rectal tumour when there are synchronous metastases. The interest of radiotherapy is debated.
Patients And Methods:
Thirty-seven patients with rectal tumour and synchronous metastases were treated with radiotherapy first between September 1994 and December 2004. We analysed the tolerance, local control, resecability, overall survival of such a therapeutic strategy.
Results:
The mean follow-up was 30 months. Twenty-four tumors were resecable for both the primary site and the metastases. Thirteen were unresecable at the time of diagnosis. Thirty-three patients were treated with radiochemotherapy, ten with radiotherapy alone. Eighty-six decimal five percent of them had no pelvic symptom six weeks after the treatment. Twenty-one rectal tumours were finally resected. The disease progressed in six cases during the radiotherapy. Surgery of the metastases was possible for 12 patients with tumour initially resecable.
Conclusion:
Radiochemotherapy is a "tolerable" treatment, in spite of more frequent urinary or digestive side-effects. But, if there is no surgery, palliative effect of radiotherapy is limited.
